CytoDyn (CYDY) Raw Materials (2020 - 2022)

CytoDyn's Raw Materials history runs 3 years deep, the most recent figure standing at $19.5 million for Q1 2022.

• Quarterly Raw Materials fell 79.13% year-over-year to $19.5 million in Q1 2022, while the trailing twelve-month figure through Feb 2022 was $19.5 million (down 79.13% YoY) and the FY2021 annual result came in at $28.1 million, up 46.68% from the prior year.
• Raw Materials was $19.5 million for Q1 2022 at CytoDyn, down from $22.5 million in the prior quarter.
• Across five years, Raw Materials topped out at $99.1 million in Q4 2020 and bottomed at $15.9 million in Q1 2020.
• A 3-year average of $42.5 million and a median of $26.0 million in 2021 frame the typical range for Raw Materials.
• Annual changes were most pronounced in 2021 — Raw Materials soared 488.45% — and 2022, when it plunged 79.13%.
• CytoDyn's Raw Materials stood at $99.1 million in 2020, then slumped by 77.25% to $22.5 million in 2021, then fell by 13.4% to $19.5 million in 2022.
• Business Quant data shows CYDY's Raw Materials at $19.5 million in Q1 2022, $22.5 million in Q4 2021, and $26.0 million in Q3 2021.